USC researchers have launched a massive scientific effort to construct a detailed, virtual 3-D model of the pancreatic beta cell and its components — a global project that aims to one day curb the worldwide rise of diabetes.
Eighteen companies ranging in maturity and focus, from software building to bag making, will be housed in the newly renovated HQ by the end of the month.
A pair of bio-oriented spaces in Baltimore are looking to provide extra help to scientists building companies out of discoveries.
The Inner Harbor–based Institute of Marine and Environmental Technology (IMET) and Baltimore Under Ground Science Space (BUGSS) have a new partnership, according to leaders from both spots.
TEDCO announced investments from its seed fund in five startups this week, including three from Baltimore.
Taken together, the latest funding from Maryland’s quasi-public agency backing early-stage companies totals $1.2 million. Here’s the funding breakdown:
Johns Hopkins University led all U.S. universities in research and development expenditures for the 38th consecutive year in fiscal year 2016, spending $2.431 billion on projects like fighting dengue, finding the functional age of cells, and explaining why the universe is making fewer stars.
Tuesday, April 10, 2018 from 6:00 PM – 8:00 PM
The National Capital SoPE Chapter is moving its meeting to the newly established Inova Personalized Health Accelerator located at 3225 Gallows Road Room C17, Fairfax, Virginia, 22031. We will meet in the Conference Center on the Inova Campus. Our first meeting for the Spring 2018 lineup will be: RED FLAGS in Healthcare/Life Science Due Diligence – What Every Investor and Entrepreneur Should Know!
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to bringing high quality, cost-effective pharmaceutical products and innovative oncology therapeutics to patients, announces today a $50 million private placement. The Company has entered into definitive securities purchase agreements pursuant to which the Company will issue 15,432,091 shares of its Common Stock with accompanying warrants to purchase 6,172,832 shares of its Common Stock. The purchase price for each share of Common Stock and warrant is $3.24. The warrants will become exercisable 180 days after issuance at a $3.69 per share exercise price, and will expire five years from the date of issuance. On March 19, 2018, the consolidated closing bid price per share of Common Stock was $3.19.
Our country faces an ever-growing number of challenges in the 21st century, but all too often our political dialogue can’t even begin to scratch the surface. While Washington remains mired in its usual partisan fights, entire communities across the country — especially in the Midwest — have been locked out of an economy that has moved away from the manufacturing base that helped build the strongest middle class the world has ever seen.
Friday, May 18, 2018 7:30AM – 3:00PM
Largest Regional Small Business Procurement Conference
MCCC GovConNet Procurement Conference gives over 800 attendees the unique opportunity to gain valuable insights and meet directly with key purchasing agents from a variety of prime contractors and federal, state, and local government agencies.
Wednesday, April 18, 20185:00 PM – 8:00 PM
Please join us on Wednesday, April 18, 2018 for a Healthcare Panel presentation and networking event at the INOVA Personalized Health Conference Center.
Cocktails and hors d’oeuvres will be provided.